Blackstone Inc.

BX

CIK 0001393818 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$4.36B
↑+41.4% +$1.28Bvs FY2024 (Q4)
Operating Income
$4.23B
↑+45.0% +$1.31Bvs FY2024 (Q4)
Net Income
$1.02B
↑+44.2% +$311Mvs FY2024 (Q4)
Gross Profit
$4.36B
↑+41.4% +$1.28Bvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
23/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    27D/E 1.45 (under 0.5 = conservative)
  • Efficiency
    9Asset Turnover 0.32x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +41.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project BX's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

3%

Trailing 3-yr CAGR was -9.3%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$81.37
Total enterprise IV
$63.48B
Diluted shares
0.78B
Terminal PV
$44.74B (70% of total)
Year-5 FCF
$5.27B
YearProjected FCFDiscounted PV
+1$4.68B$4.26B
+2$4.82B$3.99B
+3$4.97B$3.73B
+4$5.12B$3.50B
+5$5.27B$3.27B
Terminal$72.05B$44.74B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$116M
investment in PP&E
Dividends paid (TTM)
$6.01B
cash returned to holders
Stock-based comp (TTM)
$1.45B
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$47.71B
everything owned
Total liabilities
$25.83B
everything owed
Stockholders' equity
$8.67B
shareholder claim
Net debt
$9.95B
LT debt minus cash

Recent performance · 67 quarters

Revenue↑+41.4% +$1.28B
$4.36B
Net Income↑+44.2% +$311M
$1.02B
Free Cash Flow↑+599.2% +$896M
$1.05B

Drill down